Home › Entities › clinical_trial › QTc Study GSK573719+GW642444

QTc Study GSK573719+GW642444

clinical trial
MedicalStudy clinical_trial Q63320097
Press Enter · cited answer in seconds

Summary

QTc Study GSK573719+GW642444 is a clinical trial[1].

Key Facts

  • QTc Study GSK573719+GW642444 is in the country of United Kingdom[2].
  • QTc Study GSK573719+GW642444's instance of is recorded as clinical trial[3].
  • QTc Study GSK573719+GW642444's start time is recorded as +2011-12-19T00:00:00Z[4].
  • QTc Study GSK573719+GW642444's end time is recorded as +2012-06-05T00:00:00Z[5].
  • QTc Study GSK573719+GW642444's sponsor is recorded as GSK[6].
  • QTc Study GSK573719+GW642444's main subject is recorded as chronic obstructive pulmonary disease[7].
  • QTc Study GSK573719+GW642444's main subject is recorded as tolerability[8].
  • QTc Study GSK573719+GW642444's main subject is recorded as safety[9].
  • QTc Study GSK573719+GW642444's main subject is recorded as pharmacokinetics[10].
  • QTc Study GSK573719+GW642444's number of participants is recorded as {'unit': '1', 'amount': '+100'}[11].
  • QTc Study GSK573719+GW642444's title is recorded as A Randomised, Placebo-controlled, Incomplete Block, Four Period Crossover , Repeat Dose Study to Evaluate the Effect of the Inhaled GSK573719/Vilanterol Combination and GSK573719 Monotherapy on Electrocardiographic Parameters, With Moxifloxacin as a Positive Control, in Healthy Subjects.[12].
  • QTc Study GSK573719+GW642444's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[13].
  • QTc Study GSK573719+GW642444's ClinicalTrials.gov ID is recorded as NCT01521377[14].
  • QTc Study GSK573719+GW642444's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+65'}[15].
  • QTc Study GSK573719+GW642444's research intervention is recorded as moxifloxacin[16].
  • QTc Study GSK573719+GW642444's clinical trial phase is recorded as phase I clinical trial[17].
  • QTc Study GSK573719+GW642444's research site is recorded as GSK[18].
  • QTc Study GSK573719+GW642444's research subject recruitment status is recorded as completed[19].
  • QTc Study GSK573719+GW642444's study type is recorded as interventional study[20].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.
  18. [19] ↑ . wikidata.org.
  19. [20] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). QTc Study GSK573719+GW642444. Retrieved May 3, 2026, from https://4ort.xyz/entity/qtc-study-gsk573719-gw642444
MLA “QTc Study GSK573719+GW642444.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/qtc-study-gsk573719-gw642444.
BibTeX @misc{4ortxyz_qtc-study-gsk573719-gw642444_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{QTc Study GSK573719+GW642444}}, year = {2026}, url = {https://4ort.xyz/entity/qtc-study-gsk573719-gw642444}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): QTc Study GSK573719+GW642444 — https://4ort.xyz/entity/qtc-study-gsk573719-gw642444 (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/qtc-study-gsk573719-gw642444 · Last refreshed: